P1.01-78 Treatment-Related Adverse Events in Patients with Advanced NSCLC Treated with First-Line Atezolizumab Chemoimmunotherapy
| Autor: | Swarup, S. 1, Thein, K. 2, Sultan, A. 3, Jahan, N. 3, Quirch, M. 3, Meda, S. 3, Htut, T. 4, Adhikari, N. 5, Hlaing, P. 3, Dash, A. 6, Tun, A. 7, Rehman, S. 3, Hardwicke, F. 3, Tijani, L. 3 |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2019 14(10) Supplement:S390-S390 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|